Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A non-inferiority comparative analysis of micro-ultrasonography and MRI-targeted biopsy in men at risk of prostate cancer
BJU International ( IF 4.5 ) Pub Date : 2021-11-13 , DOI: 10.1111/bju.15635 Sebastian L Hofbauer 1 , Ferdinand Luger 2 , Niklas Harland 3 , Henning Plage 1 , Maximillian Reimann 1 , Markus Hollenbach 1 , Andreas Gusenleitner 2 , Arnulf Stenzl 3 , Thorsten Schlomm 1 , Laura Wiemer 1 , Hannes Cash 1, 4, 5
BJU International ( IF 4.5 ) Pub Date : 2021-11-13 , DOI: 10.1111/bju.15635 Sebastian L Hofbauer 1 , Ferdinand Luger 2 , Niklas Harland 3 , Henning Plage 1 , Maximillian Reimann 1 , Markus Hollenbach 1 , Andreas Gusenleitner 2 , Arnulf Stenzl 3 , Thorsten Schlomm 1 , Laura Wiemer 1 , Hannes Cash 1, 4, 5
Affiliation
To compare the efficacy of multiparametric magnetic resonance imaging (mpMRI)-directed and micro-ultrasonography (micro-US)-directed biopsy for detecting clinically significant (Grade Group >1) prostate cancer (csPCa).
中文翻译：
显微超声和 MRI 靶向活检在有前列腺癌风险的男性中的非劣效性比较分析
比较多参数磁共振成像 (mpMRI) 导向和显微超声 (micro-US) 导向活检在检测临床显着（Grade Group >1）前列腺癌 (csPCa) 方面的疗效。
更新日期：2021-11-13
中文翻译：
显微超声和 MRI 靶向活检在有前列腺癌风险的男性中的非劣效性比较分析
比较多参数磁共振成像 (mpMRI) 导向和显微超声 (micro-US) 导向活检在检测临床显着（Grade Group >1）前列腺癌 (csPCa) 方面的疗效。
京公网安备 11010802027423号